Ohtsu Haruhiko, Dempsey Peter J, Eguchi Satoru
Department of Physiology, Cardiovascular Research Center, Temple University School of Medicine, 3420 N. Broad St., Philadelphia, PA 19140, USA.
Am J Physiol Cell Physiol. 2006 Jul;291(1):C1-10. doi: 10.1152/ajpcell.00620.2005.
A disintegrin and metalloprotease (ADAM) is a membrane-anchored metalloprotease implicated in the ectodomain shedding of cell surface proteins, including the ligands for epidermal growth factor (EGF) receptors (EGFR)/ErbB. It has been well documented that the transactivation of the EGFR plays critical roles for many cellular functions, such as proliferation and migration mediated through multiple G protein-coupled receptors (GPCRs). Recent accumulating evidence has suggested that ADAMs are the key metalloproteases activated by several GPCR agonists to produce a mature EGFR ligand leading to the EGFR transactivation. In this review, we describe the current knowledge on ADAMs implicated in mediating EGFR transactivation. The major focus of the review will be on the possible upstream mechanisms of ADAM activation by GPCRs as well as downstream signal transduction and the pathophysiological significances of ADAM-dependent EGFR transactivation.
解整合素金属蛋白酶(ADAM)是一种锚定在膜上的金属蛋白酶,与细胞表面蛋白的胞外域脱落有关,这些蛋白包括表皮生长因子(EGF)受体(EGFR)/ErbB的配体。已有充分文献记载,EGFR的反式激活对许多细胞功能起着关键作用,如通过多种G蛋白偶联受体(GPCR)介导的增殖和迁移。最近越来越多的证据表明,ADAMs是由几种GPCR激动剂激活的关键金属蛋白酶,可产生成熟的EGFR配体,从而导致EGFR反式激活。在这篇综述中,我们描述了目前关于介导EGFR反式激活的ADAMs的知识。综述的主要重点将是GPCR激活ADAM的可能上游机制以及下游信号转导,以及ADAM依赖性EGFR反式激活的病理生理意义。